TABLE 4.
Feature | Typical | Indeterminate/suggestive |
---|---|---|
Pancreatic imaging | Diffuse enlargement with delayed enhancement without low-density mass, ductal dilation or duct cut-off ERCP: Long (>1/3 length of the main pancreatic duct) or multiple strictures without marked upstream dilation |
Segmental/focal enlargement with delayed enhancement ERCP: Segmental/focal narrowing without marked upstream dilation (duct size <5 mm) |
IgG4 | IgG4 >2 × upper limit of normal value | IgG4 1–2 × upper limit of normal value |
Histology | (Core biopsy/resection): at least 3 features
|
(Core biopsy): any 2 features
|
Response to steroids | Rapid (<2 weeks) radiological resolution or marked improvement in pancreatic or extrapancreatic manifestations | Rapid (<2 weeks) radiological resolution or marked improvement in pancreatic or extrapancreatic manifestations |
Adapted from reference 35. ERCP Endoscopic retrograde cholangiopancre-atography; hpf High-power field; Ig Immunoglobulin